The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 10th 2025
By closing the gap on patients recommended lipid-lowering therapies who do not receive them, researchers say that thousands of cardiovascular events could be prevented and billions of dollars would be saved.
Teva and Immuneering Announce Teva's Purchase of 51% Equity Share of Genomic-Analysis Company
August 3rd 2015Teva Pharmaceutical Industries Ltd. and Immuneering Corporation announced that the companies have entered into an agreement in which Teva will purchase a 51% equity share of the company.
Read More